Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Concentrated growth factor (CGF) is an autologous platelet concentrate developed by Sacco in 2006. It is obtained from venous blood through a specific differential continuous centrifugation process without using anticoagulants. CGF contains a fibrin-rich matrix with activated platelets, leukocytes (including CD34+ stem cells), and various growth factors such as TGF-β, VEGF, PDGF, EGF, and others. It serves as both a scaffold for tissue regeneration and a continuous delivery system for growth factors, promoting healing in various applications including facial rejuvenation, wound healing, bone regeneration, and dental/oral surgeries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on concentrated growth factor.